Post-Stroke Spastic Movement Disorder and Botulinum Toxin A Therapy: Early Detection And Early Injection
Jörg Wissel, Anatol Kivi
Ann Rehabil Med. 2023;47(5):326-336.   Published online 2023 Oct 23     DOI: https://doi.org/10.5535/arm.23108
Citations to this article as recorded by Crossref logo
The Role of Botulinum Toxin Type-A in Spasticity: Research Trends from a Bibliometric Analysis
Salvatore Facciorusso, Stefania Spina, Alessandro Picelli, Alessio Baricich, Gerard E. Francisco, Franco Molteni, Jörg Wissel, Andrea Santamato
Toxins.2024; 16(4): 184.     CrossRef
Botulinum Toxin in Treatments for Abnormal Movements
María Gabriela González Chico, Xaviera Elizabeth Medina Godoy, Miliana Esperanza Estupiñan Bazurto, María José López Becerra
Más Vita.2024; 6(2): 82.     CrossRef
Botulinum Toxin Type A (BoNT-A) Use for Post-Stroke Spasticity: A Multicenter Study Using Natural Language Processing and Machine Learning
María Jesús Antón, Montserrat Molina, José Gabriel Pérez, Santiago Pina, Noemí Tapiador, Beatriz De La Calle, Mónica Martínez, Paula Ortega, María Belén Ruspaggiari, Consuelo Tudela, Marta Conejo, Pedro Leno, Marta López, Carmen Marhuenda, Carlos Arias-Ca
Toxins.2024; 16(8): 340.     CrossRef
Early is Better, Then, How Early and How to Apply: Practical Approach of Botulinum Toxin Injection
Joon-Ho Shin
Annals of Rehabilitation Medicine.2023; 47(6): 439.     CrossRef